Interestingly, a 24-h treatment with FLX was able to rescue TGF-β1 concentrations in the culture media of PBMCs from young adult individuals with DS (19–35 years) to values comparable to the matched HC controls (Figure 7A, p < 0.05). The gene discussed is TGFB1; the disease is Dravet syndrome.